NCT01007032 2019-02-27
A Study of IMC-A12 in Advanced Solid Tumors
Eli Lilly and Company
Phase 1 Completed
Clinical Trials
4 trialsNCT00785538 2019-01-08
A Study of IMC-A12 in Participants With Tumors Who No Longer Respond to Treatment or For Whom No Treatment is Available
Eli Lilly and Company
Phase 1 Completed
NCT00678769 2015-11-04
Cixutumumab and Temsirolimus in Treating Patients With Locally Advanced or Metastatic Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT00785941 2011-10-13
A Study of IMC-A12 Every 2 Weeks in Patients With Tumors Who No Longer Respond to Treatment or No Treatment is Available
Eli Lilly and Company
Phase 1 Completed